/
/
/

Jenburkt Pharmaceuticals Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)997.50
Volume (₹)43.00
High (₹)997.50
Upper Circuit1,101.00
Low (₹)915.00
Lower Circuit734.00
Prev Close917.50
52W High (₹)1,321.00
Price915.00
52W Low (₹)880.10

Share Market Cap & Key Ratios Overview

M.Cap (₹)404.92 Cr
Div. Yield (%)2.26
PE Ratio12.33
Debt to Equity0.00
Price to Book2.14
Book Value446.47
EPS (TTM)74.39
Face Value10.00
ROE (%)18.84

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
LAURUSLABS-ANSE
CIPLA-ANSE
DRREDDY-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
JENBURPH-BNSE
LTP
1W Low
1W High
Market cap (₹)
1748.9-8 (-0.46%)
1725.70
1777.05
4,24,466Cr
9029.85-296.15 (-3.18%)
8938
9450
2,46,222Cr
4594-66 (-1.42%)
4557.10
4680.30
1,76,301Cr
1124+8.9 (0.80%)
1108
1150.90
1,12,818Cr
2036+3.9 (0.19%)
2008.70
2071
1,10,823Cr
1312.85+9.55 (0.73%)
1300.25
1330.60
1,07,447Cr
1214.1+19 (1.59%)
1195.65
1250.95
1,03,471Cr
2330.1-38.9 (-1.64%)
2317.80
2425.05
97,850Cr
1659.9-26.2 (-1.55%)
1654.70
1714.90
96,836Cr
1954.8-5.2 (-0.27%)
1925.85
1966.05
89,629Cr
915-30 (-3.17%)
912
997.50
405Cr

Key Highlights of Jenburkt Pharmaceuticals Ltd Balance Sheet

Jenburkt Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹4.41Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹4.41Cr, and the reserves and surplus of the company is ₹192.63Cr.

The company has its non-current liabilities with total liabilities of ₹223.61Cr as of 2026-03-31.

The current liabilities are ₹23.15Cr as of 2026-03-31. At the same time, current assets are ₹95.09Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹27.02Cr and tangible assets of ₹19.46Cr, provided in the Jenburkt Pharmaceuticals Ltd financial statements.